Conference
296 Dose ranging study of monalizumab (IPH2201) in patients with gynecologic malignancies: A trial of the Canadian Cancer Trials Group (CCTG): IND221
Authors
Tinker A; Hirte H; Provencher D; Butler M; Ritter H; Tu D; Paralejas P; Grenier N; Hahn S; Ramsahai J
Volume
69
Pagination
pp. s97-s98
Publisher
Elsevier
Publication Date
December 1, 2016
DOI
10.1016/s0959-8049(16)32889-1
Conference proceedings
European Journal of Cancer
ISSN
0959-8049